Vector control operations framework for Zika virus

Similar documents
Factsheet about Chikungunya

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16

Mosquito Control Matters

Mosquito-borne virus prevention and control: a global perspective

State of InequalIty. Reproductive, maternal, newborn and child health. executi ve S ummary

CUTANEOUS LEISHMANIASIS

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

Mosquito Control Update. Board of County Commissioners Work Session February 16, 2016

Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016

What is Zika virus (Zika)?

SEA-CD-277 FREQUENTLY ASKED QUESTIONS ON DENGUE

European Centre for Disease Prevention and Control. Zika virus disease

Interim report MRCU - February 2017 Friendly Aedes aegypti project in West Bay

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

UNDERSTANDING ZIKA AND MOSQUITO BORNE ILLNESSES

DENGUE VECTOR CONTROL: PRESENT STATUS AND FUTURE PROSPECTS

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses

CDC Responds to ZIKA Zika 101

SPECIALIZED FAMILY CARE Provider Training

MODULE 3: Transmission

Yellow fever. Key facts

Maria Eugenia Toledo Institute of Tropical Medicine Pedro Kouri, Cuba

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

Prevention of arboviral diseases. Willem Takken & Sander Koenraadt Laboratory of Entomology Wageningen University and Research

Zika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County

West Nile Virus and West Nile Encephalitis Frequently Asked Questions

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

SEA-CD-276 FREQUENTLY ASKED QUESTIONS ON CHIKUNGUNYA FEVER

Travel Health and Points of Entry: Key Considerations

MONITORING HEALTH INEQUALITY

2000s. 1900s. 1800s. Dengue Dog heartworm EEE La Crosse Malaria SLE WEE. Dengue Malaria Yellow Fever

FIRST MEETING OF THE TECHNICAL ADVISORY GROUP ON PUBLIC HEALTH ENTOMOLOGY PAN AMERICAN HEALTH ORGANIZATION

BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA

Israel Journal of Entomology Vol. XXXH (1998) pp FIELD TRIALS TO DETERMINE THE EFFECTIVENESS OF BACILLUS

Where is Yellow Fever found?

Vector Hazard Report: CHIKV in the Americas and Caribbean

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

3/24/2017. CDC S Response to Zika ZIKA 101. Updated February 2, 2017 INTRODUCTION

Mosquito Threats in LA County West Nile virus & Zika

Epidemiological Characteristics of Clinically- Confirmed Cases of Chikungunya in Teculutan, Guatemala

Summary report on the WHO-EM/CSR/124/E

Zika 101 for Occupational Safety and Health Professionals

General Description. Significance

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

BOVA Network - Building Out Vector-borne diseases in sub-saharan Africa. First BOVA Open Network Meeting IEDE-UCL, London, 28 th March 2018

Disease spread primarily through the bite of an infected Aedes aegypti or Ae. albopictus mosquito.

What You Need to Know ZIKA VIRUS

West Nile Virus Los Angeles County

Oxitec Mosquito Vector Control Technology. A New Paradigm to combat Dengue, chikungunya and the emerging threat of Zika

The International Health Regulations (2005) Vector Surveillance and Control at PoE

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE

Fact sheet. Yellow fever

INJURY OR DEATH FROM WEST NILE, ZIKA OR OTHER VIRUSES VECTORED BY MOSQUITOES

Annual report MRCU - June 2017 Friendly Aedes aegypti project in West Bay

Zika and the Threat to Pregnant Women and Their Babies: How Your Local Health Departments Works to Keep Communities Safe

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive

West Nile Virus Surveillance and Response Plan

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

Photo Book: Identify Signs of Illness

ZIKA VIRUS. John J. Russell MD May 27, 2016

THE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group

Friendly Aedes aegypti An effective tool to fight the mosquito that transmits dengue, chikungunya and Zika

May 24, School Superintendents and School Board Members:

Mosquito Threats in Burbank West Nile virus and Zika Update. Presented by Kelly Middleton, Director of Community Affairs

MOSQUITO CONTROL PLAN

CASE STUDY: Global Health on CAB Direct Aedes mosquitoes carriers of Zika virus

Zika Virus Response Planning: Interim Guidance for District and School Administrators in the Continental United States and Hawaii

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version

Mosquitoes in Your Backy a rd

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Health and Diseases Managing the Spread of Infectious Diseases

Zika as a reportable condition Testing approval and result notification Zika pregnancy registry Is there a risk of local transmission?

Zika Virus Update. Wednesday, 25 May :00 11:00. PRESENTED BY: Dr. Michael Braida

Chikungunya outbreak in New Caledonia in 2011 Status report as at 22 August 2011

Biology, distribution, and insecticide susceptibility status of Florida vectors of Zika virus.

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Local Health Departments: Preparing for and Preventing Zika. March 23, 2016

Zika Virus and Control Efforts in Arizona

Latent tuberculosis infection

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES

BEST PRACTICES FOR PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities

2015 Mosquito Abatement Plan QUALITY OF LIFE & ENVIRONMENT COMMITTEE MARCH 23, 2015

ZIKA VIRUS. Facts & Figures

Aedes aegypti Larval Habitats and Dengue Vector Indices in a Village of Ubonratchathani Province in the North-East of Thailand

The public health response to dengue virus is important in order to:

Integrating Aedes Into Existing Malaria Vector Control Systems In Africa

Mosquito Surveillance/Control in Texas

Breaking the transmission cycle of Dengue Virus. James P. Sainsbury

WHO Emergency Risk Communication

The importance of schools and other non-household sites for dengue entomological risk

Arbovirus Surveillance in Massachusetts 2016 Massachusetts Department of Public Health (MDPH) Arbovirus Surveillance Program

SUPERIOR COURT OF THE STATE OF CALIFORNIA

Save the Children s Zika Virus Response: Addressing Education and Personal Protection Needs in the Americas Request for Support

EWARN Weekly Summary Report

Transcription:

Vector control operations framework for Zika virus

WHO/ZIKV/VC/16.4 Acknowledgements: This document was developed by staff from the WHO Department of Control of Neglected Tropical Diseases (Raman Velayudhan, Rajpal Yadav, Anna Drexler), Global Malaria Programme (Abraham Mnzava, Martha Quinones, Tessa Knox, Emmanuel Temu) and the Special Programme for Tropical Disease Research (Florence Fouque), Geneva. Review of the content was kindly provided by FAO and UNICEF. World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications whether for sale or for non-commercial distribution should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

Contents Introduction... 4 Vector control options... 5 Personal protection measures... 7 New vector control tools... 8 Vector control strategies... 9 3

Introduction Zika virus is primarily transmitted by the Aedes species of mosquito which is also responsible for the spread of dengue, Chikungunya and yellow fever viruses. In most areas, the primary vector of these viruses is Aedes aegypti, with Aedes albopictus a proven or potential vector in some settings. Well-implemented vector control against Aedes using existing tools effectively reduces the transmission of viruses spread by these vectors. Pilot studies are being undertaken on new tools which have potential for future reductions in Aedes populations. Efforts to prevent Zika virus transmission should prioritise the intensification of control measures against Aedes using existing tools. Although one recent study 1 has examined the effectiveness of community mobilization for dengue prevention, vector control tools for Aedes control have not yet been evaluated for disease impact. For rapid impact, surveillance and control should build on existing national structures rather than seeking to establish new or parallel structures. In many countries of Africa, this will entail augmenting existing capacity in malaria control programmes. In some countries of the Americas, South-East Asia and the Western Pacific existing dengue control programmes can be built on. Such leveraging of existing human, infrastructure and organizational resources will facilitate more rapid and effective response to the threat or an outbreak of Zika virus disease. Additional impact on other significant Aedes-borne diseases may also result. Prevention should target all Aedes mosquito life stages Ae. aegypti are day-biting mosquitoes while Ae. albopictus usually bite in the early morning and late afternoon. Ae. aegypti typically rest indoors and fly short distances up to 80 metres. Eggs are usually laid in artificial containers found in and around homes such as those used for domestic water storage and decorative plants as well as rain-filled habitats like used tyres, discarded food and beverage containers and blocked gutters. Ae. albopictus tend to rest outdoors and inhabit both domestic and peri-domestic artificial containers (e.g. rubber tapping cups filled with rain water, roof gutters etc.) as well as natural receptacles such as tree holes and plants. Ground pools and other stagnant water bodies are not usually preferred for egg laying by either species. Eggs hatch into immature larvae which develop into pupae and then emerge out of the water as adult mosquitoes. Anti-mosquito efforts can therefore target the destruction of eggs, larval or pupae in these water containers, or can target the adult mosquitoes where they fly, feed or rest. Surveillance must be conducted concurrently Entomological surveillance is vital for any good vector control initiative. Vigilant monitoring at points of entry is imperative for countries at risk of Aedes introduction. For areas with established populations, monitoring Aedes at immature (mainly larvae and pupae) and adult life stages should be undertaken. For immatures, it is essential to know the key containers in a given setting as studies have shown that as few as 3-5 container types can sustain 80% of the total pupal population in an area. This requires an assessment to quantify larval and/or pupal populations across all containers in the area. Knowledge of the spatial distribution, density, and resting sites of adults are also important if this stage will be targeted for control. The species composition and their susceptibility to insecticides either in use or planned for use should also be determined. This information will facilitate appropriate and timely decision-making for interventions. Further details can be found in Entomological surveillance for Aedes spp. in the context of Zika virus and Monitoring and managing insecticide resistance in Aedes mosquito populations (available online from http://www.who.int/csr/resources/publications/zika/en/). 1 Andersson, N et al. Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial. BMJ, 2015; 351:h3267. doi: 10.1136/bmj.h3267. 4

Vector control options Measures targeting eggs, larvae and pupae Given that Aedes mosquitoes are domestic, families and the general community must be actively involved in eliminating mosquito breeding sites from their homes. These should be accompanied by appropriate community sensitisation, engagement and mobilisation along with a well-coordinated risk communication strategy. Based on assessment of the most productive key containers in an area, the following control measures should be carried out. For small water receptacles such as discards and other waste Conduct community clean-up campaigns to remove or destroy small discards that are serving as water receptacles, such as plastic containers, tin cans or scrap metal. Ensure tyres are stored properly, removed to landfill sites or recycled. Clean roof gutters and home coolers. For medium to large containers that hold water for domestic use Empty, clean and scrub to remove eggs and other immature stages each week before refilling. Place tight-fitting covers to prevent female mosquitoes from laying eggs. Introduce larvicides recommended by the WHO Pesticide Evaluation Scheme (WHOPES) to kill immature mosquitoes. For other large containers such as ornamental pools, wells and cisterns Introduce native larvivorous fish or other larvivorous aquatic insects. For irrigation and storm water canals or other relevant water bodies Implement efficient irrigation practices such as weekly flushing. Improve drainage. Fill temporary pools. Ensure gutters are free flowing without any stagnant pools. Numerous options are available for larvicides including WHOPES-recommended insecticides, insect growth regulators or biological control agents 2. These can be effective when used correctly, provided that the vector populations are susceptible. Many slow release formulations are now available for larval control. 2 World Health Organization. WHOPES-recommended compounds and formulations for control of mosquito larvae. Geneva, 18 March 2016. Available online from http://who.int/entity/whopes/mosquito_larvicides_march_2016.pdf (accessed 24 May 2016). 5

Measures targeting adult mosquitoes Targeted residual spraying Targeted residual spraying is the primary vector control intervention for immediate response. It is performed using appropriate insecticides applied on Ae. aegypti resting sites such as exposed lower sections of walls (<1.5m), under furniture, inside closets, in dark and moist surface where mosquitoes may rest in and to a lesser extent, around houses. Targeted residual spraying is applied selectively to areas known to be resting sites for the Aedes mosquito it does not require the spraying of all exposed surfaces in houses. Suitable insecticides can be applied with hand-operated compression sprayers. Power sprayers can be used to treat large accumulations of discarded containers (e.g. tyre dumps) rapidly, if no other option is possible. Care must be taken not to treat containers used to store water intended for drinking or cooking. Space spraying In the event of a vector-borne disease outbreak, authorities should implement space spraying with the objective of killing adult vectors in order to reduce virus transmission. An appropriate WHOPESrecommended insecticide should be selected 3 on the basis on information on the susceptibility of the local Aedes population. Indoor space spraying is more effective than outdoor treatment if deployed properly inside buildings where Aedes mosquitoes rest and bite. Space spraying targets adult mosquitoes while they are in flight and has no residual effect; its application outdoors may not reach all mosquitoes especially those indoors. Recommended application techniques include ultra-low volume space spraying (cold fog or thermal fog) and using portable backpack sprayers or thermal foggers, which vaporize liquid insecticide into droplets to form an aerosol or fog with a rapid knockdown effect on mosquitoes. 3 World Health Organization. WHO recommended insecticides for space spraying against mosquitoes. Geneva, 5 February 2016. Available online from http://who.int/entity/whopes/space_spray_products_february_2016.pdf (accessed 24 May 2016). 6

Personal protection measures Health authorities should advise residents and travellers to any country with documented Zika virus transmission to take the necessary measures to protect themselves from day-biting mosquitoes. This is especially important for pregnant women. Recommended measures include: Application of repellents to exposed skin or clothing, which should contain DEET (N, N-diethyl- 3- methylbenzamide), IR3535 (3-[N-acetyl-N-butyl]-aminopropionic acid ethyl ester) or Icaridin (1- piperidinecarboxylic acid, 2-(2-hydroxyethyl)-1-methylpropylester). Repellents must be used in strict accordance with the label instructions, and if used as such, are safe for pregnant women. Wearing clothing that minimizes skin exposure to mosquito bites during daylight hours, when mosquitoes that transmit Zika virus are most active. Using window screens, door screens and air-conditioning in buildings to discourage day-time entry, biting and resting of Aedes. Using WHOPES-recommended long-lasting insecticidal mosquito nets 4 when sleeping or resting during the day (e.g. for pregnant women, infants, elderly or sick individuals). It is important that people infected with Zika virus or other mosquito-borne diseases protect themselves from mosquito bites to prevent further transmission. Patients, their household members, and the community should be educated about the risk of transmission and how to minimize this risk by reducing contact with mosquitoes. Zika virus may circulate in areas where other mosquito-borne diseases are present (e.g. dengue, yellow fever or Chikungunya,). Special measures for pregnant women Countries affected by Zika virus can explore special protection measures for pregnant women. This can include giving repellent lotion and a treated mosquito net (for use while sleeping during the day) to pregnant women who visit health centres to confirm pregnancies or for regular check-ups. Advocacy and one-on-one communication on the key personal protective measures for Zika virus and other Aedes borne diseases should also be provided. Interventions targeting pregnant women should be evaluated for safety during implementation. 4 World Health Organization. WHO recommended long-lasting insecticidal nets. Geneva, 1 April 2016. Available online at http://who.int/whopes/long-lasting_insecticidal_nets_april_2016.pdf (accessed 24 May 2016). 7

New vector control tools Several promising potential new vector control tools have been reviewed by WHO in the context of the response to Zika virus. These have the potential to reduce vector populations and/or viral multiplication to minimal levels and thereby to prevent transmission. While several tools are supported by strong evidence of entomological effect, there is a lack of comprehensive data on epidemiological impact for any Aedesborne viruses. Thus, full-scale programmatic deployment is not currently recommended. However available evidence warrants the pilot deployment of two of the new tools under operational conditions, accompanied by rigorous independent monitoring and evaluation. Randomized controlled trials with epidemiological outcomes should be carried out to build evidence for the use of these tools to control Aedes-borne diseases. 1. Microbial control of human pathogens in adult vectors (Wolbachia): Available evidence indicates that a strain of symbiotic Wolbachia spp. bacteria (wmel), when introduced into Ae. aegypti populations, reduce the ability of the mosquitoes to transmit arboviruses to humans. Laboratory results show that wmel Wolbachia infection reduces the replication of dengue, Chikungunya and Zika viruses within Aedes mosquitoes, and eliminates or substantially delays the appearance of virus in mosquito saliva, thus reducing the competence of the mosquito to transmit viruses. Implementing this tool involves establishing and sustaining wmel Wolbachia in local Aedes mosquito populations, thereby providing ongoing protection from virus transmission. 2. Mosquito population reduction through genetic manipulation: OX513A is a transgenic strain of Ae. aegypti engineered to carry a dominant, repressible, non-sex-specific, late-acting lethal genetic system, together with a fluorescent marker. Larvae carrying the OX513A gene develop normally, but die before functional adulthood. This technology has been demonstrated to reduce Ae. aegypti populations in small-scale field trials in several countries, but there is an absence of data on epidemiological impact. Implementing this tool requires the sustained release of transgenic male mosquitoes to maintain suppression of wild Ae. aegypti populations. The timing and decision on a pilot deployment of the above tools will depend on factors including: appropriate regulatory and ethical clearance by host countries; sufficient community engagement and acceptance of the intervention; scale of the planned pilot; capacity of the host country to deploy, sustain, and properly monitor the pilot; manufacturing scalability (e.g. ability to produce the quantity of OX513A or Wolbachia-carrying mosquitoes required within a given timeframe); ecological and epidemiological considerations at the chosen pilot site. Pilot deployment should be accompanied by a robust monitoring and evaluation system to ensure that evidence is generated on the effectiveness of the new intervention. The decision to deploy new tools should be guided by national regulations and international best practices, including maintenance of existing effective vector control during pilot deployment. Such a decision should involve country regulatory authorities, disease specific health departments and medical research institutes. 8

Vector control strategies A. Actions to be taken in countries without Aedes Countries and regions should enhance and strengthen capacity for surveillance of both vector populations and arboviral diseases. Existing surveillance networks should be leveraged to strengthen surveillance and data sharing in order to monitor the spread of arboviruses, the dynamics and insecticide susceptibility status of vector populations, and the risk of disease outbreaks. Such surveillance should be an integral part of a comprehensive epidemic preparedness, surveillance and response system. B. Actions to be taken in countries with Aedes, but no evidence of Zika virus circulation I. Responsible ministries at national and state levels must play a direct and pro-active role. Programme authorities should implement entomological surveillance and vector control at the scale needed to prevent or control Zika virus transmission. To be most effective, action must be taken before an increase in Zika virus cases occurs. II. Promote mobilization of the whole community. This includes intersectoral collaboration with the participation of sectors such as health, education, environment, local government, social development and tourism. Non-governmental organizations, operational partners and private entities should also be engaged. C. Actions to be taken in countries with Aedes and evidence of Zika virus transmission I. Stratify areas. Following a situation analysis and stratification exercise, areas with the highest transmission (highest numbers of cases) or that are at the highest risk of transmission (high density of vectors) should be prioritised. Where priority areas encompass large populations such as in cities, sub-priority areas should be identified for intensified vector control. A situation analysis should include an assessment of the insecticide resistance status of target vector species, including the gathering of new data if this is lacking. II. Understand and prioritise local vector breeding sites to target reduction strategies. Adult and immature populations should be assessed frequently to inform the development of broad, comprehensive vector control measures. An analysis of Aedes aquatic habitats in the locality/community will help to identify the most productive containers for prioritised vector control. The assessment should incorporate larval and/or pupal counts as indicators for identifying these productive containers. III. Implement adult control measures. Adult control measures, primarily using targeted residual spraying and/or space spraying, should be implemented along with source reduction measures for at least 4-6 weeks to significantly reduce vector density in areas of high transmission. 9

Risk communication and social mobilisation In countries with confirmed Zika virus transmission, national public health authorities should implement social mobilisation strategies and develop a risk communication strategy. Authorities should seek to engage the community in vector control and to apply personal protection measures. The mobilisation of community groups for regular door-to-door campaigns should be encouraged. The elimination of breeding habitats and simultaneous implementation of larvicide and adulticide treatments are essential to achieve a rapid decline in mosquito densities, and to reduce or interrupt virus transmission. While these are necessary emergency measures during an outbreak, the most effective intervention for prevention and protection is the elimination of mosquito aquatic habitats, the use of screens on doors and windows in houses, and other personal protection measures. Country Context Table 1. Vector control operational strategies according to country context Countries without Aedes Countries with Aedes, but no evidence of Zika virus circulation Countries with Aedes and evidence of Zika virus transmission Category A B C Monitor points of entry for Aedes species introduction Intensify immature and/or adult entomological surveillance, including identification of key containers producing the highest number of immatures Implement source reduction measures Integrate source reduction measures with disease surveillance Apply larvicides to key containers not amenable to source reduction Conduct community education and mobilisation Conduct adult vector control in areas with Zika virus transmission or high risk, preferably using targeted residual spraying Conduct insecticide resistance monitoring of Aedes mosquitoes where insecticidal interventions are in use or planned Promote personal protection, including the appropriate use of repellents (B, C) and mosquito nets (B,C) Monitor and evaluate the quality and impact of control measures 10